From Appeals to Adoption: Accelerating Change in Personalized Medicine Reimbursement

The Promise of Personalized Medicine

The fight for reimbursement often feels like navigating a maze. From lengthy appeals to prior authorizations, labs and healthcare providers must balance innovation with complex payer policies. But what if this process could be less adversarial, more collaborative, and streamlined with the help of cutting-edge technology?

Our guest today is Tom Cronin, Senior Vice President, Revenue Cycle Strategy & Analytics at Quadax. Quadax is the leading and trusted healthcare partner delivering revenue cycle optimization solutions driven by the needs of our clients, powered by business analytics, and supported by superior service to improve reimbursement of care.

Tom acknowledges that while appeals can be a necessary tactic to challenge denied coverage, they are costly and time-consuming. He contrasts older adversarial approaches with today’s more collaborative methods, where payers increasingly appreciate the economic value of tests in the long-term healthcare of patients. He explains how medical policies and prior authorizations play a critical role in determining coverage, while also discussing the evolving trend of health plans requesting medical records electronically to streamline the process.

The conversation also covers technological advancements that could alleviate administrative burdens, such as AI and natural language processing to assist in reviewing medical records. While these technologies are promising, both share that health plans and labs still need human oversight in making final coverage decisions.

—----

For more information about Quadax, please visit https://www.quadax.com/

Stay connected with our host, Perry Dimas, here on LinkedIn!